New eye gel aims to make cataract surgery safer
NCT ID NCT07279506
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new surgical gel, IXIUM TWIN, designed to protect the eye during cataract surgery. About 180 adults having cataract surgery will receive either the new gel or an approved one to see if it causes less damage to the eye's inner lining. The goal is to offer surgeons a safe, effective option for keeping the eye stable during the procedure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CATARACT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple stress ball or favorite tune replace anxiety meds during eye surgery?
- Can a bangkok community eye check reveal hidden glaucoma risks?
- Can trifocal lens implants keep night driving safe and clear?
- Which cataract tool works better? a Head-to-Head test in the same eyes
- Eye scans may forecast lens misalignment after cataract surgery
- Can a stronger eye drop dose shield the retina after cataract surgery?